表紙
市場調査レポート

医療機器:技術および世界市場

Medical Devices: Technologies and Global Markets

発行 BCC Research 商品コード 311939
出版日 ページ情報 英文 309 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
医療機器:技術および世界市場 Medical Devices: Technologies and Global Markets
出版日: 2014年09月08日 ページ情報: 英文 309 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の医療機器市場は2012年に3,903億米ドル、2013年には4,118億米ドル規模となりました。同市場は2018年には5,387億米ドルに拡大し、今後5年間でCAGR5.5%で推移すると予測されています。

当レポートは、世界の医療機器市場の概要と、2018年までの市場動向予測、医療機器の種類と関連法規制、および市場に参入する主要企業のプロファイルと市場シェアなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 医療機器技術業界における技術革新
    • 医療機器技術業界における現況
    • 医療技術の定義、発展、種類
    • 法規制
    • RoHS II
    • 市場動向
    • 戦略
    • 流通網
    • 動向
    • 新製品と技術
    • 新材料
    • 修理・置換市場
    • 合併・買収
    • 提言

第4章 世界の医療機器技術市場

  • 概要
  • 画像装置
  • 体外診断装置
  • 免疫化学
  • ポイントオブケア診断
  • 分子診断
  • ファーマコゲノミクス
  • 血液検査
  • 心血管装置
  • 心調律管理
  • 心臓カテーテル技術
  • 整形外科・脊椎技術
  • 泌尿器装置
  • 腎臓透析装置
  • 内視鏡装置
  • ドラッグデリバリー装置

第5章 地域別医療機器技術市場

  • 北米
  • 欧州
  • アジア
  • 中国
  • その他の諸国

第6章 競合環境

第7章 企業プロファイル

第8章 特許分析

図表

目次
Product Code: HLC170A

REPORT HIGHLIGHTS

BCC Research estimates the global market for medical device technologies as $390.3 billion in 2012. This indication has reached $411.8 billion in 2013 and is expected to reach $538.7 billion in 2018, registering a compound annual growth (CAGR) of 5.5% over the next five years.

This report provides:

  • An overview of the global medical devices market.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion of definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies.
  • Information on the refurbished and replacement market, mergers and acquisitions, market shares for key players, and trends broken down by geography, new technology, and new materials used.
  • An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems.
  • Comprehensive company profiles of major players in the industry.

SCOPE OF THE REPORT

This research report incorporates an in-depth analysis of the medical device technologies market, including market estimations and trends through 2018. Major players, competitive intelligence, innovative technologies, market dynamics and geographic opportunities are discussed in detail in the report. The report also examines recent developments and product portfolios of the major players along with their market shares. Patent analysis in the report focuses on technological trends in recent years in geographies such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device technologies.

The scope of the report extends to only those medical device technologies that generate the most revenue globally. However, we have excluded dental device technologies as some imaging devices used in dentistry overlap with other devices already covered under the imaging device technologies segments.

ANALYST'S CREDENTIALS

Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • MARKET DESCRIPTION
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • RESEARCH METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2012-2018 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • INNOVATIONS IN THE MEDICAL DEVICE TECHNOLOGIES INDUSTRY
    • CURRENT TRENDS IN THE MEDICAL DEVICE TECHNOLOGIES INDUSTRY
    • DEFINITION, EVOLUTION AND TYPES OF MEDICAL TECHNOLOGIES
      • Definition
      • Evolution
      • Types
    • REGULATIONS AND LEGISLATIONS
      • Europe
    • ROHS II
      • U.S.
      • China
      • Japan
      • India
      • Others
        • Indonesia
        • Korea
        • Malaysia
        • The Philippines
        • Singapore
        • Taiwan
        • Australia
        • Hong Kong
        • Vietnam
    • MARKET DYNAMICS
      • Drivers
        • Aging Global Population
          • FIGURE 1 PERCENTAGE OF THE POPULATION OVER 60 YEARS OF AGE, BY REGION, 2013 (%)
        • Increase in Lifestyle and Chronic Diseases
          • FIGURE 2 PROJECTED GROWTH OF DIABETES ACROSS THE TOTAL GLOBAL POPULATION, 2010 AND 2030 (%)
        • Molecular Medicine and Minimally Invasive Techniques
        • Other Drivers
      • Restraints
      • Opportunities
    • STRATEGIES
    • DISTRIBUTION NETWORK
      • Asia
      • United States
      • Europe
      • India
      • China
      • Others
        • Japan
        • Korea
    • TRENDS
      • China
      • Europe
    • NEW PRODUCTS AND TECHNOLOGIES
    • NEW MATERIALS
    • REFURBISHED/REPLACEMENT MARKET
    • MERGERS AND ACQUISITIONS
    • RECOMMENDATIONS

CHAPTER 4 - GLOBAL MEDICAL DEVICE TECHNOLOGIES MARKET

  • OVERVIEW
    • TABLE 1: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • IMAGING DEVICES
    • TABLE 2: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • MARKET DYNAMICS
      • Increased Life Expectancy
      • Growing Incidence of Diseases
      • Improvement in Medical Device Technologies
      • Legislative Amendments and Other Initiatives
      • Resistance to New Technology-based Systems Due to High Costs
      • Excise Duties Levied Under the Patient Protection and Affordable Care Act (PPACA)
      • Large Population Base in Emerging Economies
      • Increasing Government Spending on Healthcare and Healthcare Infrastructure
        • TABLE 3: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • MAGNETIC IMAGING RESONANCE
      • Market Dynamics
        • FIGURE 3: GLOBAL NUMBER OF PATIENTS WITH CHRONIC DISEASES, 2005-2030 (MILLIONS)
        • TABLE 4: GLOBAL MARKET FOR MRI TECHNOLOGY BY REGION,THROUGH 2018 ($ MILLIONS)
      • Innovation and New Products
        • GE Healthcare
        • Toshiba
        • Siemens
        • Hitachi
        • Philips
      • Trends
        • FIGURE 4: MARKET SHARE OF KEY COMPANIES IN THE MRI TECHNOLOGIES MARKET, 2012 (%)
    • ULTRASOUND TECHNOLOGIES MARKET
      • Market Dynamics
        • FIGURE 5: TOP 10 COUNTRIES WITH THE HIGHEST PERCENTAGE PEOPLE AGED 60 AND OVER, 2011 (%)
        • FIGURE 6: TOP 10 COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF PEOPLE AGED 60 AND OVER, 2050 (%)
      • New Product Innovations
      • Market Trends
        • TABLE 5: GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
        • FIGURE 7: COMPANY MARKET SHARES OF ULTRASOUND TECHNOLOGIES, 2012 (%)
    • LASER IMAGING MARKET
      • TABLE 6: GLOBAL MARKET FOR LASER IMAGING DEVICES TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 8: GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE, 2010-2050 (MILLIONS)
      • New Product Innovations
      • Market Trends
        • FIGURE 9: COMPANY SHARES FOR LASER IMAGING MARKET, 2012 (%)
    • INTERVENTIONAL RADIOLOGY MARKET
      • TABLE 7: GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 10: NUMBER OF ANGIOPLASTY PROCEDURES CONDUCTED GLOBALLY, 2009-2012 (NO. OF PROCEDURES)
        • FIGURE 11: NUMBER OF STENTS USED IN CORONARY PROCEDURES GLOBALLY, 2009-2012 (NO. OF STENTS)
      • Innovation and New Products
      • Market Trends
    • X-RAY
      • TABLE 8: GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market dynamics
        • FIGURE 12: PACS PROCESS OF OBTAINING IMAGES
        • FIGURE 13: GLOBAL PERCENTAGE OF POPULATION BY AGE GROUP, 2000-2050 (%)
        • TABLE 9: TARGET DISEASE STATISTICS
      • Innovation and New products
      • Market Trends
        • FIGURE 14: X-RAY MARKET COMPANY SHARES, 2012 (%)
    • COMPUTER TOMOGRAPHY
      • TABLE 10: GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 15: INSTANCES OF CORONARY HEART DISEASE IN SELECTED COUNTRIES, 2012 (%)
      • Innovation and New Products
        • GE Healthcare
        • Phillips
    • NUCLEAR MEDICINE/ POSITRON EMISSION TOMOGRAPHY (PET)
      • TABLE 11: GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market dynamics
        • FIGURE 16: PERCENTAGE OF GLOBAL CARDIOVASCULAR MORTALITY BY INCOME LEVEL, 2011 (%)
      • Innovation and New products
      • Market Trends
        • TABLE 12: REIMBURSEMENT POLICIES BY THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE U.S.
      • Market share of key players
    • POINT OF CARE TECHNOLOGIES
      • TABLE 13: GLOBAL MARKET FOR POINT OF CARE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
      • Innovation and New Products
      • Market Trends
      • Market Share of Key Players
  • IN VITRO DIAGNOSTIC DEVICES
    • TABLE 14: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 17: HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA, 2009-2011 ($ BILLIONS)
    • Overall in Vitro Diagnostics Market Share
      • FIGURE 18: IN VITRO DIAGNOSTICS MARKET COMPANY MARKET SHARES, 2012 (%)
    • Professional In Vitro Diagnostics Market Share
      • FIGURE 19: PROFESSIONAL DIAGNOSTICS MARKET COMPANY MARKET SHARES, 2012 (%)
    • Types of In Vitro Diagnosis
      • Immunoassays
      • Diabetes Testing
      • Blood Testing/ Hematology
      • Molecular Diagnosis
        • TABLE 15: GLOBAL MARKET FOR IN VITRO DIAGNOSTICS TECHNOLOGIES BY SEGMENTS, THROUGH 2018 ($ MILLIONS)
  • REGULATIONS
  • IVD MARKET BY GEOGRAPHY
  • IMMUNOCHEMISTRY
    • TABLE 16: GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION,THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 20: INSTANCES OF CARDIOVASCULAR DISEASE IN SELECTED REGIONS, 2012 (%)
    • FIGURE 21: NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO. OF INFECTIONS)
  • INNOVATION AND NEW PRODUCTS
  • TRENDS
  • MARKET SHARE OF KEY PLAYERS
    • FIGURE 22: IMMUNOASSAY MARKET SHARES FOR INFECTIOUS DISEASES (EXCLUDING HEPATITIS AND RETROVIRUS), 2012 (%)
    • FIGURE 23: IMMUNOASSAY MARKET SHARES FOR HEPATITIS AND RETROVIRUS, 2012 (%)
    • FIGURE 24: IMMUNOASSAY MARKET SHARES FOR ONCOLOGY AND ENDOCRINOLOGY, 2012 (%)
    • FIGURE 25: IMMUNOASSAY MARKET SHARES FOR NUCLEIC ACID TESTING, 2012 (%)
    • TABLE 17: GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • POINT-OF-CARE DIAGNOSTICS MARKET
    • TABLE 18: POINT-OF-CARE DIAGNOSTICS TESTS AND MANUFACTURERS
    • TABLE 19: INCIDENCE OF DIABETES FOR THE TOP 10 COUNTRIES, 2013 (THOUSANDS)
    • FIGURE 26: REGIONAL PREVALENCE OF DIABETES BY AGE GROUPS, 2013 (THOUSANDS)
    • FIGURE 27: SHIFT OF USAGE OF POINT OF CARE DIAGNOSTIC SOLUTIONS
    • TABLE 20: GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • INNOVATION AND NEW PRODUCTS
  • TRENDS
    • FIGURE 28: U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS)
    • TABLE 21: POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS VARIOUS PRODUCT SEGMENTS
  • COMPETITIVE LANDSCAPE
    • FIGURE 29: POINT-OF-CARE DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%)
  • MOLECULAR DIAGNOSTICS
    • TABLE 22: GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • GROWING GLOBAL PREVALENCE OF HOSPITAL-ACQUIRED AND HPV INFECTIONS
    • FIGURE 30: APPLICATION PERCENTAGE OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE SEGMENTS (%)
  • PHARMACOGENOMICS
  • MARKET TRENDS
    • U.S.
    • China
    • India
    • Overall Market Trends
  • COMPETITIVE LANDSCAPE
    • FIGURE 31: MOLECULAR DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%)
  • BLOOD TESTING (HEMATOLOGY/ HEMOSTASIS)
    • TABLE 23: GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • MARKET TRENDS
      • U.S.
      • China
    • COMPETITIVE LANDSCAPE
  • CARDIOVASCULAR DEVICE MARKET
    • TABLE 24: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TYPES OF CARDIOVASCULAR DISEASES
    • Cardiac Arrhythmia
      • TABLE 25: ABLATION TYPES AND THEIR MECHANISMS
    • Coronary Blockages
      • TABLE 26: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 32: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
    • INTERVENTIONAL CARDIOLOGY DEVICES
      • Stents
        • FIGURE 33: EVOLUTION OF CORONARY STENTS
        • TABLE 27: INCIDENCE PERCENTAGE OF RESTENOSIS BY STENT TYPE
        • TABLE 28: DRUG ELUTING STENT PRODUCTS AND MANUFACTURERS
        • TABLE 29: BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS
      • PTCA Balloons
        • TABLE 30: COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM
      • PTCA Guidewires
      • PTCA Guiding Catheters
      • Angiography Catheters
      • Balloon Inflation Devices
        • TABLE 31: PRODUCTS AND MANUFACTURERS
      • Intravascular Ultrasound
      • Cardiovascular Device Market Trends
    • REGULATIONS
  • CARDIAC RHYTHM MANAGEMENT MARKET
    • TABLE 32: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • MARKET DYNAMICS
      • FIGURE 34: GLOBAL POPULATION BASE TO 65 YEARS AND ABOVE, 2000-2050 (%)
    • MARKET TRENDS
      • Pharmacological Treatment
        • TABLE 33: ANTI- ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
        • TABLE 34: ANTI-ARRHYTHMIC DRUGS: CLASSIFICATION AND CLINICAL USAGE
      • Non-pharmacological Treatment
      • Maze Surgery Procedures
      • Electric Cardioversion Procedures
      • Global Market Trends
    • COMPETITIVE RIVALRY
  • CARDIAC CATHETERIZATION TECHNOLOGIES
    • TABLE 35: GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • MARKET DYNAMICS
    • INNOVATION AND NEW PRODUCTS
  • ORTHOPEDIC AND SPINAL TECHNOLOGIES
    • TABLE 36: GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES, BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • MARKET DYNAMICS
    • GEOGRAPHY
      • TABLE 37: GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
    • REGULATIONS
  • RECONSTRUCTIVE IMPLANTS
    • TABLE 38: GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • MARKET DYNAMICS
      • FIGURE 35: NUMBER OF OSTEOPOROTIC HIP FRACTURES BY REGION, 1990-2050 (THOUSANDS)
    • INNOVATION AND NEW PRODUCTS
    • TRENDS
    • MARKET SHARE
      • FIGURE 36: RECONSTRUCTIVE IMPLANT TECHNOLOGIES COMPANY MARKET SHARES, 2012 (%)
    • SPINAL IMPLANTS
      • TABLE 39: GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
      • Market Trends
        • TABLE 40: FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES
      • Innovation and New products
      • Market Share Analysis
        • FIGURE 37: SPINAL IMPLANT COMPANY MARKET SHARES, 2012 (%)
    • TRAUMA FIXATION DEVICE TECHNOLOGIES MARKET
      • TABLE 41: GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 38 TRAUMA DEVICE FIXATION COMPANY MARKET SHARES, 2012 (%)
      • Orthopedic Robotic Systems
        • TABLE 42: GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
      • Major Orthopedic Robotic Systems
      • MAKO RIO Surgical System
      • Stanmore Sculptor Robotic Guidance Arm (RGA)
      • NavioPFS Surgical System
      • iBlock surgical system
      • ROBODOC Surgical System
  • UROLOGY DEVICE MARKET
    • TABLE 43: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • TABLE 44: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • MEDICAL LASER SYSTEMS FOR UROLOGY
    • TABLE 45: GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2018 ($ MILLIONS)
  • GEOGRAPHY
    • FIGURE 39: GLOBAL PREVALENCE OF KIDNEY DISEASE, 2012 (%)
  • REGULATIONS
  • INCONTINENCE DEVICES
    • Market Dynamics
      • FIGURE 40: LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS)
  • TRENDS
    • TABLE 46: GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 41: GROWTH (MILLION) IN THE GLOBAL POPULATION BASE OVER THE AGE OF 60 YEARS, 2010 TO 2017 (%)
  • INNOVATION AND NEW PRODUCTS
  • MARKET SHARES
    • Ostomy Care Device Market
      • FIGURE 42: OSTOMY CARE DEVICE COMPANY MARKET SHARES, 2012 (%)
    • Incontinence Care Device Market
      • FIGURE 43: INCONTINENCE CARE DEVICE COMPANY MARKET SHARES, 2012 (%)
  • RENAL DIALYSIS DEVICE MARKET
    • TABLE 47: GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • FIGURE 44 RENAL DIALYSIS DEVICE COMPANY MARKET SHARES, 2012 (%)
  • ENDOSCOPY DEVICES
    • TABLE 48: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • TYPES
    • TABLE 49: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 45: GLOBAL PREVALENCE OF COLON CANCER BY AGE
  • RIGID ENDOSCOPES
    • TABLE 50: GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Dynamics
  • FLEXIBLE ENDOSCOPES
    • TABLE 51: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Dynamics
  • INNOVATION AND NEW PRODUCTS
  • DRUG DELIVERY DEVICES
    • TABLE 52: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
  • MARKET DYNAMICS
    • Increasing Prevalence of Cardiovascular Disease
    • Increasing Global Prevalence of Prostate Cancer
    • Emergence of New Disease Applications (Cervical Cancer, Breast Cancer)
    • Growing Global Elderly Population Base
    • Rising Prevalence of Diabetes and Diabetic Retinopathy
    • Growing Prevalence of Unwanted Pregnancies
    • Government and NGO Initiatives to Promote Contraceptive Products
    • Introduction of New and Advanced Implantable Drug Delivery
    • Devices
    • Introduction of Biodegradable Technology Products
    • Product Recalls, Lawsuits and the Introduction of Internal Product Substitutes
    • "Stringent FDA and CE Approval Norms
  • INFUSION SYSTEMS
    • TABLE 54: GLOBAL MARKET FOR INFUSION SYSTEM AND INJECTABLE DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Dynamics
      • Rising Global Prevalence of Colorectal Cancer
      • High Prevalence of Chronic Pain Causing Disorders
    • Innovation and New products
    • Market Trends
  • INHALATION DEVICES
    • TABLE 55: GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Dynamics
    • Innovation and New Products
    • Trends
  • NEEDLE-FREE INJECTIONS/TRANSDERMAL SYSTEMS
    • TABLE 56: GLOBAL MARKET FOR NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • Market Dynamics
    • New Product Developments
    • Market Trends
      • TABLE 57: MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES

CHAPTER 5 - MEDICAL DEVICE TECHNOLOGIES MARKET BY REGION

  • NORTH AMERICA
    • TABLE 58: NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • EUROPE
    • TABLE 59: EUROPEAN MARKET FOR MEDICAL DEVICES TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • ASIA
    • TABLE 60: ASIA MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
  • CHINA
  • ROW
    • TABLE 61 ROW MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)

CHAPTER 6 - COMPETITIVE LANDSCAPE

  • FIGURE 46: COMMON STRATEGIES FOLLOWED BY PLAYERS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (%)
  • TABLE 62: PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
  • TABLE 63: MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
  • TABLE 64: AGREEMENTS/JOINT VENTURES/EXPANSION/DIVESTMENT AND INVESTMENT IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
  • TABLE 65: CERTIFICATION/REORGANIZATION/R&D FACILITIES/SERVICES AND SOLUTIONS/OTHERS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
  • TABLE 66: CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)

CHAPTER 7 - COMPANY PROFILES

  • 3M
    • TABLE 67: 3M PRODUCT PORTFOLIO
    • TABLE 68: 3M RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • ABBOTT LABORATORIES
    • TABLE 69: ABBOTT LABORATORIES PRODUCT PORTFOLIO
    • TABLE 70: ABBOTT LABORATORIES RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • AGILENT TECHNOLOGIES
    • TABLE 71: AGILENT PRODUCT PORTFOLIO
    • TABLE 72: AGILENT RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • BAYER
    • TABLE 73: BAYER HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 74: BAYER HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • BAXTER INTERNATIONAL
    • TABLE 75: BAXTER INTERNATIONAL PRODUCT PORTFOLIO
    • TABLE 76: BAXTER INTERNATIONAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • BECKTON, DICKINSON AND CO. (BD)
    • TABLE 77: BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
    • TABLE 78: BECKTON, DICKINSON AND COMPANY RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • BOSTON SCIENTIFIC
    • TABLE 79: BOSTON SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 80: BOSTON SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • CARDINAL HEALTH
    • TABLE 81: CARDINAL HEALTH PRODUCT PORTFOLIO
    • TABLE 82: CARDINAL HEALTH RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • COVIDIEN
    • TABLE 83: COVIDIEN PRODUCT PORTFOLIO
    • TABLE 84: COVIDIEN RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • DANAHER
    • TABLE 85: DANAHER PRODUCT PORTFOLIO
    • TABLE 86: DANAHER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • DRAGER
    • TABLE 87: DRAGER PRODUCT PORTFOLIO
    • TABLE 88: DRAGER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • FRESENIUS
    • TABLE 89: FRESENIUS PRODUCT PORTFOLIO
    • TABLE 90: FRESENIUS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • GE HEALTHCARE
    • TABLE 91: GE HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 92: GE HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • GETINGE AB
    • TABLE 93: GETINGE AB PRODUCT PORTFOLIO
    • TABLE 94: GETINGE AB RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • HOSPIRA
    • TABLE 95: HOSPIRA PRODUCT PORTFOLIO
    • TABLE 96: HOSPIRA RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • JOHNSON & JOHNSON
    • TABLE 97: JOHNSON & JOHNSON PRODUCT PORTFOLIO
    • TABLE 98: JOHNSON & JOHNSON RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • KIMBERLY-CLARK HEALTH CARE
    • TABLE 99: KIMBERLY-CLARK HEALTH CARE PRODUCT PORTFOLIO
    • TABLE 100: KIMBERLY-CLARK HEALTH CARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • MEDTRONIC
    • TABLE 101: MEDTRONIC PRODUCT PORTFOLIO
    • TABLE 102: MEDTRONIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • NOVARTIS
    • TABLE 103: NOVARTIS PRODUCT PORTFOLIO
    • TABLE 104: NOVARTIS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • OLYMPUS COPORATION
    • TABLE 105: OLYMPUS CORP. PRODUCT PORTFOLIO
    • TABLE 106: OLYMPUS CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • PALL CORP.
    • TABLE 107: PALL CORP. PRODUCT PORTFOLIO
    • TABLE 108: PALL CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • PHILIPS HEALTHCARE
    • TABLE 109: PHILIPS PRODUCT PORTFOLIO
    • TABLE 110: PHILIPS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • ROCHE DIAGNOSTICS
    • TABLE 111: ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
    • TABLE 112: ROCHE DIAGNOSTICS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • SAINT JUDE MEDICAL
    • TABLE 113: SAINT JUDE MEDICAL PRODUCT PORTFOLIO
    • TABLE 114: SAINT JUDE MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • SIEMENS HEALTHCARE
    • TABLE 115: SIEMENS HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 116: SIEMENS HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • SMITH & NEPHEW
    • TABLE 117: SMITH & NEPHEW PRODUCT PORTFOLIO
    • TABLE 118: SMITH & NEPHEW RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • SMITHS MEDICAL
    • TABLE 119: SMITHS MEDICAL PRODUCT PORTFOLIO
    • TABLE 120: SMITHS MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • STRYKER CORP.
    • TABLE 121: STRYKER CORP. PRODUCT PORTFOLIO
    • TABLE 122: STRYKER CORP. RECENT DEVELOPMENTS (2011 TO FEBRUARY 2014)
  • SYNTHES
    • TABLE 123: SYNTHES PRODUCT PORTFOLIO
    • TABLE 124: SYNTHES RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • TELEFLEX
    • TABLE 125: TELEFLEX PRODUCT PORTFOLIO
    • TABLE 126: TELEFLEX RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • THERMO FISHER SCIENTIFIC
    • TABLE 127: THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 128: THERMO FISHER SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • TOSHIBA MEDICAL SYSTEMS CORP.
    • TABLE 129: TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
    • TABLE 130: TOSHIBA MEDICAL SYSTEMS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
  • ZIMMER HOLDINGS
    • TABLE 131: ZIMMER HOLDINGS PRODUCT PORTFOLIO
    • TABLE 132: ZIMMER HOLDINGS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)

CHAPTER 8 - PATENT ANALYSIS

  • FIGURE 47: MEDICAL DEVICE TECHNOLOGIES PATENTS BY REGION, 2011-2014 (%)
  • TABLE 133: LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN THE U.S. (2011-2014)
  • TABLE 134: LIST OF MEDICAL DEVICE TECHNOLGIES PATENTS FILED IN EUROPE 2011-2014
  • TABLE 135: LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN JAPAN (2011-2014)

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 1: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES, BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 2: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 3: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 4: GLOBAL MARKET FOR MRI TECHNOLOGY BY REGION,THROUGH 2018 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 6: GLOBAL MARKET FOR LASER IMAGING DEVICES TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 7: GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 8: GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 9: TARGET DISEASE STATISTICS
    • TABLE 10: GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 11: GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 12: REIMBURSEMENT POLICIES BY THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE U.S.
    • TABLE 13: GLOBAL MARKET FOR POINT OF CARE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR IN VITRO DIAGNOSTICS TECHNOLOGIES BY SEGMENTS, THROUGH 2018 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION,THROUGH 2018 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 18: POINT-OF-CARE DIAGNOSTICS TESTS AND MANUFACTURERS
    • TABLE 19: INCIDENCE OF DIABETES FOR THE TOP 10 COUNTRIES, 2013 (THOUSANDS)
    • TABLE 20: GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 21: POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS VARIOUS PRODUCT SEGMENTS
    • TABLE 22: GLOBAL MARKET FOR MOLECULAR DIAGNOSTICS TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 25: ABLATION TYPES AND THEIR MECHANISMS
    • TABLE 26: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 27: INCIDENCE PERCENTAGE OF RESTENOSIS BY STENT TYPE
    • TABLE 28: DRUG ELUTING STENT PRODUCTS AND MANUFACTURERS
    • TABLE 29: BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS
    • TABLE 30: COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM
    • TABLE 31: PRODUCTS AND MANUFACTURERS
    • TABLE 32: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 33: ANTI- ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
    • TABLE 34: ANTI-ARRHYTHMIC DRUGS: CLASSIFICATION AND CLINICAL USAGE
    • TABLE 35: GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES, BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES, BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 40: FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES
    • TABLE 41: GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 44: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 45: GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 46: GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 47: GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 48: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 49: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 50: GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICES TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 51: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 52: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 54: GLOBAL MARKET FOR INFUSION SYSTEM AND INJEC
    • TABLE DE: ICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 55: GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 56: GLOBAL MARKET FOR NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS TECHNOLOGIES BY REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 57: MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
    • TABLE 58: NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 59: EUROPEAN MARKET FOR MEDICAL DEVICES TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 60: ASIA MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 61: ROW MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2018 ($ MILLIONS)
    • TABLE 62: PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 63: MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 64: AGREEMENTS/JOINT VENTURES/EXPANSION/DIVESTMENT AND INVESTMENT IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 65: CERTIFICATION/REORGANIZATION/R&D FACILITIES/SERVICES AND SOLUTIONS/OTHERS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 66: CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 67: 3M PRODUCT PORTFOLIO
    • TABLE 68: 3M RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 69: ABBOTT LABORATORIES PRODUCT PORTFOLIO
    • TABLE 70: ABBOTT LABORATORIES RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 71: AGILENT PRODUCT PORTFOLIO
    • TABLE 72: AGILENT RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 73: BAYER HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 74: BAYER HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 75: BAXTER INTERNATIONAL PRODUCT PORTFOLIO
    • TABLE 76: BAXTER INTERNATIONAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 77: BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
    • TABLE 78: BECKTON, DICKINSON AND COMPANY RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 79: BOSTON SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 80: BOSTON SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 81: CARDINAL HEALTH PRODUCT PORTFOLIO
    • TABLE 82: CARDINAL HEALTH RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 83: COVIDIEN PRODUCT PORTFOLIO
    • TABLE 84: COVIDIEN RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 85: DANAHER PRODUCT PORTFOLIO
    • TABLE 86: DANAHER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 87: DRAGER PRODUCT PORTFOLIO
    • TABLE 88: DRAGER RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 89: FRESENIUS PRODUCT PORTFOLIO
    • TABLE 90: FRESENIUS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 91: GE HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 92: GE HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 93: GETINGE AB PRODUCT PORTFOLIO
    • TABLE 94: GETINGE AB RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 95: HOSPIRA PRODUCT PORTFOLIO
    • TABLE 96: HOSPIRA RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 97: JOHNSON & JOHNSON PRODUCT PORTFOLIO
    • TABLE 98: JOHNSON & JOHNSON RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 99 : IMBERLY-CLARK HEALTH CARE PRODUCT PORTFOLIO
    • TABLE 100: KIMBERLY-CLARK HEALTH CARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 101: MEDTRONIC PRODUCT PORTFOLIO
    • TABLE 102: MEDTRONIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 103: NOVARTIS PRODUCT PORTFOLIO
    • TABLE 104: NOVARTIS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 105: OLYMPUS CORP. PRODUCT PORTFOLIO
    • TABLE 106: OLYMPUS CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 107: PALL CORP. PRODUCT PORTFOLIO
    • TABLE 108: PALL CORP. RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 109: PHILIPS PRODUCT PORTFOLIO
    • TABLE 110: PHILIPS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 111: ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
    • TABLE 112: ROCHE DIAGNOSTICS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 113: SAINT JUDE MEDICAL PRODUCT PORTFOLIO
    • TABLE 114: SAINT JUDE MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 115: SIEMENS HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 116: SIEMENS HEALTHCARE RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 117: SMITH & NEPHEW PRODUCT PORTFOLIO
    • TABLE 118: SMITH & NEPHEW RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 119: SMITHS MEDICAL PRODUCT PORTFOLIO
    • TABLE 120: SMITHS MEDICAL RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 121: STRYKER CORP. PRODUCT PORTFOLIO
    • TABLE 122: STRYKER CORP. RECENT DEVELOPMENTS (2011 TO FEBRUARY 2014)
    • TABLE 123: SYNTHES PRODUCT PORTFOLIO
    • TABLE 124: SYNTHES RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 125: TELEFLEX PRODUCT PORTFOLIO
    • TABLE 126: TELEFLEX RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 127: THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 128: THERMO FISHER SCIENTIFIC RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 129: TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
    • TABLE 130: TOSHIBA MEDICAL SYSTEMS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 131: ZIMMER HOLDINGS PRODUCT PORTFOLIO
    • TABLE 132: ZIMMER HOLDINGS RECENT DEVELOPMENTS (JANUARY 2011 TO FEBRUARY 2014)
    • TABLE 133: LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN THE U.S. (2011-2014)
    • TABLE 134: LIST OF MEDICAL DEVICE TECHNOLGIES PATENTS FILED IN EUROPE 2011-2014
    • TABLE 135: LIST OF MEDICAL DEVICE TECHNOLOGIES PATENTS FILED IN JAPAN (2011-2014)

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2012-2018 ($ MILLIONS)
    • FIGURE 1: PERCENTAGE OF THE POPULATION OVER 60 YEARS OF AGE, BY REGION, 2013 (%)
    • FIGURE 2: PROJECTED GROWTH OF DIABETES ACROSS THE TOTAL GLOBAL POPULATION, 2010 AND 2030 (%)
    • FIGURE 3: GLOBAL NUMBER OF PATIENTS WITH CHRONIC DISEASES, 2005-2030 (MILLIONS)
    • FIGURE 4: MARKET SHARE OF KEY COMPANIES IN THE MRI TECHNOLOGIES MARKET, 2012 (%)
    • FIGURE 5: TOP 10 COUNTRIES WITH THE HIGHEST PERCENTAGE PEOPLE AGED 60 AND OVER, 2011 (%)
    • FIGURE 6: TOP 10 COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF PEOPLE AGED 60 AND OVER, 2050 (%)
    • FIGURE 7: COMPANY MARKET SHARES OF ULTRASOUND TECHNOLOGIES, 2012 (%)
    • FIGURE 8: GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE, 2010-2050 (MILLIONS)
    • FIGURE 9: COMPANY SHARES FOR LASER IMAGING MARKET, 2012 (%)
    • FIGURE 10: NUMBER OF ANGIOPLASTY PROCEDURES CONDUCTED GLOBALLY, 2009-2012 (NO. OF PROCEDURES)
    • FIGURE 11: NUMBER OF STENTS USED IN CORONARY PROCEDURES GLOBALLY, 2009-2012 (NO. OF STENTS)
    • FIGURE 12: PACS PROCESS OF OBTAINING IMAGES
    • FIGURE 13: GLOBAL PERCENTAGE OF POPULATION BY AGE GROUP, 2000-2050 (%)
    • FIGURE 14: X-RAY MARKET COMPANY SHARES, 2012 (%)
    • FIGURE 15: INSTANCES OF CORONARY HEART DISEASE IN SELECTED COUNTRIES, 2012 (%)
    • FIGURE 16: PERCENTAGE OF GLOBAL CARDIOVASCULAR MORTALITY BY INCOME LEVEL, 2011 (%)
    • FIGURE 17: HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA, 2009-2011 ($ BILLIONS)
    • FIGURE 18: IN VITRO DIAGNOSTICS MARKET COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 19: PROFESSIONAL DIAGNOSTICS MARKET COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 20: INSTANCES OF CARDIOVASCULAR DISEASE IN SELECTED REGIONS, 2012 (%)
    • FIGURE 21: NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO. OF INFECTIONS)
    • FIGURE 22: IMMUNOASSAY MARKET SHARES FOR INFECTIOUS DISEASES (EXCLUDING HEPATITIS AND RETROVIRUS), 2012 (%)
    • FIGURE 23: IMMUNOASSAY MARKET SHARES FOR HEPATITIS AND RETROVIRUS, 2012 (%)
    • FIGURE 24: IMMUNOASSAY MARKET SHARES FOR ONCOLOGY AND ENDOCRINOLOGY, 2012 (%)
    • FIGURE 25: IMMUNOASSAY MARKET SHARES FOR NUCLEIC ACID TESTING, 2012 (%)
    • FIGURE 26: REGIONAL PREVALENCE OF DIABETES BY AGE GROUPS, 2013 (THOUSANDS)
    • FIGURE 27: SHIFT OF USAGE OF POINT OF CARE DIAGNOSTIC SOLUTIONS
    • FIGURE 28: U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS)
    • FIGURE 29: POINT-OF-CARE DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 30: APPLICATION PERCENTAGE OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE SEGMENTS (%)
    • FIGURE 31: MOLECULAR DIAGNOSTICS COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 32: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
    • FIGURE 33: EVOLUTION OF CORONARY STENTS
    • FIGURE 34: GLOBAL POPULATION BASE TO 65 YEARS AND ABOVE, 2000-2050 (%)
    • FIGURE 35: NUMBER OF OSTEOPOROTIC HIP FRACTURES BY REGION, 1990-2050 (THOUSANDS)
    • FIGURE 36: RECONSTRUCTIVE IMPLANT TECHNOLOGIES COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 37: SPINAL IMPLANT COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 38: TRAUMA DEVICE FIXATION COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 39: GLOBAL PREVALENCE OF KIDNEY DISEASE, 2012 (%)
    • FIGURE 40: LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS)
    • FIGURE 41: GROWTH (MILLION) IN THE GLOBAL POPULATION BASE OVER THE AGE OF 60 YEARS, 2010 TO 2017 (%)
    • FIGURE 42: OSTOMY CARE DEVICE COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 43: INCONTINENCE CARE DEVICE COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 44: RENAL DIALYSIS DEVICE COMPANY MARKET SHARES, 2012 (%)
    • FIGURE 45: GLOBAL PREVALENCE OF COLON CANCER BY AGE
    • FIGURE 46: COMMON STRATEGIES FOLLOWED BY PLAYERS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET (%)
    • FIGURE 47: MEDICAL DEVICE TECHNOLOGIES PATENTS BY REGION, 2011-2014 (%)
Back to Top